Summary:
The Ulcerative Colitis Research Study
A clinical research study for people diagnosed with Ulcerative Colitis
The Ulcerative Colitis Research Study is a clinical research study to evaluate an investigational drug for individuals who have had unsuccessful response to previous biological treatments.
You may qualify for this clinical research study if you:
- Are 18 to 75 years of age
- Have been diagnosed with Ulcerative Colitis for at least 3 months
- Have had an unsuccessful response to previous biologic treatments such as: Remicade, Humira, Simponi and/or Entyvio.
All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related time and travel may be available.